ArticleBMC cardiovascular disorders2025
Isolated pulmonary valve infective endocarditis in isolated congenital supravalvular pulmonary stenosis: a case report.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Features of Adult Patients with Isolated Pulmonary Valve Endocarditis: A Systematic Review.Microorganisms · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundIsolated pulmonary valve stenosis, of which supravalvular pulmonary stenosis is a subcategory, rarely occurs in live births. Isolated pulmonary valve infective endocarditis is uncommon and typically arises in settings of recurrent transient bacteremia, immunodeficiency, or congenital heart disease. Any infective endocarditis carries high morbidity with complications commonly including congestive heart failure, acute renal failure, and septic emboli among others. Consistent with previously published cases of pulmonary valve infective endocarditis, these cases can be challenging to diagnose and treat. CASE PRESENTATION: We present the case of a 52-year-old male with well-controlled human immunodeficiency virus on antiviral therapy and known non-syndromic congenital supravalvular pulmonary stenosis who developed pulmonary valve infective endocarditis. He originally presented to the emergency room with acute delirium and was diagnosed with Streptococcus agalactiae meningitis and bacteremia due to suspected pharyngitis, but despite antibiotics, progressed to meningoencephalitis and septic shock. His transthoracic echocardiogram was without evidence of infective endocarditis; however, a transesophageal echocardiogram was performed due to a high index of suspicion and confirmed the diagnosis. The patient subsequently required right ventricular outflow tract pericardial patch repair and replacement of the pulmonary valve with a bioprosthetic valve. At follow-up, he was asymptomatic and tolerating rehabilitation.
conclusionsPulmonary valve infective endocarditis can be difficult to diagnose because of limited sensitivity on transthoracic echocardiography and often underappreciated predisposing factors such as simple congenital heart disease. This case provides a reminder to providers of a rare, life-threatening entity that requires a high index of suspicion to diagnose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.